ASPI - NASDAQ
ASP Isotopes Inc. Common Stock
$7.55
+5.6%ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
At a Glance
Live SnapshotASP Isotopes Inc. Common Stock Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
ASP Isotopes Inc. Common Stock Cash Flow Statement
ASPI • NASDAQ
| ASP Isotopes Inc. Common Stock Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
-175.1M | -32.4M | -16.3M | -4.9M | -2.6M | |
1.9M | 471.4B | 37.4K | 72.6K | 19.4K | |
-45K | -143.3K | 16.7K | -72.6K | 0.0 | |
0.0 | 8.6M | 8.7M | 2M | 0.0 | |
139.1M | -471.4B | 924.1K | -28K | 2.2M | |
-3.6M | -2.6M | 1.2M | 33.9K | -238.2K | |
-37.8M | -16.7M | -5.4M | -2.9M | -577.7K | |
INVESTING ACTIVITIES | |||||
-9.7M | -11.4M | -2.3M | -4.5M | -3M | |
(25.4M) | (0.0) | -121.8K | (0.0) | (0.0) | |
-75.7M | (0.0) | (0.0) | (0.0) | (0.0) | |
-30M | 0.0 | 0.0 | 0.0 | 0.0 | |
-90M | -11.4M | -2.5M | -4.5M | -3M | |
FINANCING ACTIVITIES | |||||
307.1M | 53.1M | 14.1M | 8.1M | 6.5M | |
44.1M | 25.7M | -180.5K | -13K | 46.9K | |
(0.0) | -2,779.7B | (0.0) | (0.0) | (0.0) | |
-402K | 2,779.7B | -563.5K | -1.5M | 0.0 | |
350.8M | 82.5M | 13.4M | 6.6M | 6.5M | |
CASH FLOW SUMMARY | |||||
647K | -484K | -867.0 | 207.4K | 0.0 | |
223.7M | 54M | 5.5M | -564.6K | 2.9M | |
61.9M | 7.9M | 2.4M | 3M | 18.7K | |
285.6M | 61.9M | 7.9M | 2.4M | 3M | |
-47.4M | -28.1M | -7.7M | -7.4M | -3.6M |
SEC Filings
ASPI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 26, 2026 | May 26, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 20, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 20, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 10, 2026 | 2026 | |
10-K 10-K 2025 FY FY | April 10, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 24, 2026 | March 24, 2026 | 2026 |
Related Guides
Continue your ASPI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.